What is thin basement membrane disease?

Thin basement membrane disease, also called thin basement membrane nephropathy, is a common inherited cause of persistent microscopic hematuria. On electron microscopy the glomerular basement membrane is uniformly thin, about 150 to 225 nm instead of the normal 300 to 400 nm, while kidney function, blood pressure and complement are normal and proteinuria is minimal or absent. Its known cause is a heterozygous variant in COL4A3 or COL4A4, inherited in an autosomal dominant pattern, although testing does not find a variant in every patient.

Is thin basement membrane disease a form of Alport syndrome?

Increasingly, yes. Heterozygous COL4A3 or COL4A4 variants affect the same type IV collagen network as Alport syndrome, so the 2018 Alport Syndrome Classification Working Group proposed calling this autosomal dominant Alport syndrome, and GeneReviews uses that term. Many textbooks and exam questions still say thin basement membrane disease. The classic contrast remains: X-linked Alport in males brings hearing loss, anterior lenticonus, progressive kidney failure and a basket-weave basement membrane, which thin basement membrane disease usually lacks.

Can thin basement membrane disease lead to kidney failure?

Rarely, but it is no longer considered completely benign. Without risk factors the estimated risk of kidney failure is under 1%, but it rises to roughly 20% in people who develop proteinuria, reduced kidney function, or focal segmental glomerulosclerosis or basement membrane lamellation on biopsy, and in those with relatives who have progressive kidney disease. Blood pressure, urine albumin and eGFR are therefore checked regularly, and an ACE inhibitor or ARB is started if albuminuria appears.

How is thin basement membrane disease diagnosed?

It is suspected when a person has persistent microscopic hematuria with dysmorphic red cells, normal kidney function, little or no proteinuria and often a family history of the same finding. A typical case is often diagnosed clinically once other causes are excluded. When confirmation is needed, genetic testing with a panel that includes COL4A3, COL4A4 and COL4A5 is now preferred over biopsy. If a kidney biopsy is done, it shows normal light microscopy, negative immunofluorescence and diffuse thinning of the glomerular basement membrane on electron microscopy.

How do you tell thin basement membrane disease from IgA nephropathy?

Both cause hematuria in young adults with normal complement, so the history and the biopsy decide. IgA nephropathy classically causes visible hematuria one to two days after a febrile mucosal illness such as an upper respiratory infection, often with some proteinuria, and immunofluorescence shows granular IgA and C3 in the mesangium. Thin basement membrane disease causes persistent, isolated microscopic hematuria, often in several relatives, with negative immunofluorescence and a uniformly thin basement membrane.

Can someone with thin basement membrane disease donate a kidney?

Living donation is discouraged. People with a heterozygous COL4A3 or COL4A4 variant have a higher risk of kidney failure than the general population, and giving away a kidney could add to that risk. GeneReviews describes donation as a last-resort option that is not advisable before age 40, or at any age when there are signs of kidney damage such as albuminuria or reduced GFR, and it recommends a kidney biopsy before considering older donors with normal tests.

Thin Basement Membrane Disease: USMLE Case vs Alport & IgA

Thin basement membrane disease (TBMD, also called thin basement membrane nephropathy) is persistent, isolated glomerular microscopic hematuria with a uniformly thin glomerular basement membrane (GBM) on electron microscopy, normal kidney function and blood pressure, and little or no proteinuria. Its known genetic cause is a heterozygous pathogenic variant in COL4A3 or COL4A4 (the α3 and α4 chains of type IV collagen), inherited autosomal dominantly, although testing does not find a variant in every patient; genetics references therefore place it on the Alport spectrum ("autosomal dominant Alport syndrome") and have dropped the old label "benign familial hematuria." On a USMLE stem it is the well young patient with years of microscopic hematuria, a relative with the same, normal C3 and negative immunofluorescence. The outlook is usually excellent, but blood pressure, albuminuria and kidney function still need regular checks.

The question

A 22-year-old man is referred after a pre-employment urinalysis showed blood. Two repeat urinalyses over 6 months each show 2+ blood and 15-20 RBCs per high-power field; microscopy shows dysmorphic RBCs and no casts. His urine albumin-to-creatinine ratio is 12 mg/g. He has never seen blood in his urine and reports no recent infections or flank pain. Blood pressure is 118/74 mm Hg, and hearing and an eye examination are normal. His 51-year-old father has had microscopic hematuria since his twenties with normal kidney function, and his paternal grandmother had the same. Serum creatinine is 0.9 mg/dL, C3 and C4 are normal, and a renal ultrasound is normal. A kidney biopsy shows normal glomeruli on light microscopy, negative immunofluorescence, and diffuse, uniform thinning of the GBM to about 190 nm on electron microscopy, with no splitting or lamellation. Which of the following is the most likely diagnosis?

A. Alport syndrome caused by a COL4A5 variant B. Anti-glomerular basement membrane (anti-GBM) disease C. IgA nephropathy D. Nephrolithiasis E. Poststreptococcal glomerulonephritis F. Thin basement membrane disease

Answer: F. Persistent isolated glomerular hematuria + normal creatinine, blood pressure, albuminuria and complement + negative immunofluorescence + an autosomal dominant family pattern + uniform GBM thinning = TBMD. The father-to-son transmission also rules out any X-linked disorder: a father passes his Y chromosome, not his X, to his sons.

Why every answer choice matters

A. Alport syndrome (COL4A5, X-linked): the closest distractor

Why it tempts: same type IV collagen network, hematuria from childhood, and diffuse GBM thinning is the earliest Alport lesion; children with X-linked or autosomal recessive Alport often show only thinning.
Why it's wrong: male-to-male transmission excludes X-linked inheritance. Hemizygous males develop proteinuria and progressive CKD, 50-60% develop sensorineural hearing loss, and about half reach kidney failure by age 35 (GeneReviews). Over time, EM shows irregular thickening and thinning with a split, lamellated "basket-weave" lamina densa; the eye can show anterior lenticonus.
Trap: in a girl or woman with hematuria and a thin GBM, consider X-linked Alport (a heterozygous COL4A5 variant), especially if male relatives have kidney failure or deafness. More in the Alport syndrome question breakdown.

B. Anti-GBM disease

Why it tempts: "basement membrane" is in both names, and the Goodpasture antigen is the noncollagenous (NC1) domain of the α3 chain of type IV collagen, the very protein COL4A3 encodes.
Why it's wrong: anti-GBM disease is rapidly progressive glomerulonephritis: rapidly falling kidney function, RBC casts, crescents and linear IgG along the GBM on immunofluorescence, with pulmonary hemorrhage in Goodpasture syndrome. Years of stable function and negative immunofluorescence exclude it.
Link worth knowing: people with Alport syndrome can develop anti-GBM disease after a kidney transplant (mostly males), because the new kidney contains normal type IV collagen that their immune system can treat as foreign.

C. IgA nephropathy

Why it tempts: it is the most common glomerulonephritis worldwide, peaks in the 20s and 30s, is more common in males and can present as asymptomatic microscopic hematuria.
Why it's wrong: its signature is gross hematuria 1-2 days after a febrile mucosal illness ("synpharyngitic"), often with mild proteinuria, and the biopsy shows mesangial expansion with granular mesangial IgA and C3. This biopsy has none of that.
Trap: complement is usually normal in IgA nephropathy too, so a normal C3 does not separate the two; immunofluorescence (or genetic testing) does. Compare the timelines in IgA nephropathy vs post-strep GN.

D. Nephrolithiasis

Why it tempts: hematuria with normal kidney function in a young man.
Why it's wrong: stones typically cause colicky flank pain, which he denies, and his ultrasound is normal. Dysmorphic RBCs point to a glomerular source rather than the collecting system: the cells are thought to be deformed as they squeeze through gaps in the GBM.

E. Poststreptococcal glomerulonephritis (PSGN)

Why it tempts: postinfectious GN, classically poststreptococcal, is the most common cause of acute glomerulonephritis in children aged 3-15, and hematuria is its headline.
Why it's wrong: PSGN is an acute nephritic syndrome 6-21 days (up to 6 weeks) after a streptococcal throat or skin infection: edema, hypertension, cola-colored urine, RBC casts and a low C3 that returns to normal within 6-8 weeks in 80% of patients. Biopsy shows granular IgG and C3 with subepithelial "humps." This patient has years of stable hematuria and a normal C3.

F. Thin basement membrane disease: correct

Everything fits: isolated, persistent glomerular hematuria with normal kidney function, blood pressure, albuminuria and complement; an autosomal dominant family pattern; negative immunofluorescence; and uniform GBM thinning without lamellation.

Collagen IV disorders on one table

Genotype	Label	Kidneys	Ears and eyes	Electron microscopy
Heterozygous COL4A3 or COL4A4	TBMD, or autosomal dominant Alport syndrome (ADAS)	Persistent or intermittent microscopic hematuria in about half of carriers; proteinuria more frequent with age; kidney failure uncommon and usually late	Hearing loss uncommon and very late if it occurs; eye changes rare	Uniform thinning; lamellation may appear in those who progress
Hemizygous COL4A5 (male)	X-linked Alport syndrome	Hematuria, then proteinuria; about 50% reach kidney failure by age 35	Sensorineural hearing loss in 50-60%; anterior lenticonus	Thinning early, then thickening, splitting and basket-weave
Heterozygous COL4A5 (female)	X-linked Alport, female	Microhematuria very common; kidney failure in about 20% by age 60	Hearing loss less frequent and later; eye changes rare	May show only thinning
Biallelic COL4A3 or COL4A4	Autosomal recessive Alport syndrome	Significant proteinuria in childhood; kidney failure before age 30 in most; both sexes	Similar to X-linked males, in both sexes	As in X-linked males

Pathophysiology: why a thin GBM bleeds

The mature GBM is built on a type IV collagen α3α4α5 network. COL4A3 and COL4A4 sit on chromosome 2; COL4A5 is on the X chromosome (review collagen types I-IV).
With one faulty COL4A3 or COL4A4 allele, abnormal chains misfold and are degraded early. The GBM ends up thin, fragile and sensitive to proteases, and transient ruptures let red cells escape into Bowman space.
Normal adult GBM is about 300-400 nm thick; in TBMD it is about 150-225 nm (Merck). Labs typically call an adult GBM thin below about 250 nm (cut-offs vary with technique and are lower in children), and the thinning must be widespread, not patchy.
Light microscopy is normal and immunofluorescence is negative (at most nonspecific mesangial IgM or C3), because nothing immune is happening.

Presentation and diagnosis

Common: heterozygous COL4A3 or COL4A4 pathogenic variants are found in about 1 in 106 people (GeneReviews), and TBMD is one of the most frequent, and most underrecognized, causes of glomerular bleeding in children and adults.
Family history is present in one-half to two-thirds; the rest reflect new variants or incomplete penetrance.
Urine: persistent microscopic hematuria found incidentally, with dysmorphic RBCs. Gross hematuria occurs in only 5-22%, more often in children and often after an infection or exercise. Proteinuria is uncommon, usually below the nephrotic range, and becomes more likely with age.
Everything else is normal: creatinine, blood pressure at presentation, complement, hearing and eyes.
Confirming it: a typical case (isolated hematuria, normal function and blood pressure, affected relatives) is often diagnosed clinically once other causes are excluded, and StatPearls notes that genetic testing is generally not required for that. When confirmation matters (proteinuria, hypertension, falling eGFR, Alport-like features, possible X-linked inheritance, or a would-be kidney donor), genetic testing with a panel that includes COL4A3, COL4A4 and COL4A5 is now preferred over biopsy: the Alport classification summary in Kidney Medicine (2020) calls it the gold standard, and GeneReviews keeps kidney biopsy for when genetic testing is unavailable or uninformative.
Wider hematuria-proteinuria sorting: nephrotic vs nephritic syndrome.

Prognosis and management: "benign," with a footnote

Classic teaching (still in Merck): long-term prognosis is excellent and most patients need no treatment.
Current view: TBMD is no longer considered universally benign. The risk of kidney failure is under 1% without risk factors but roughly 20% with them: proteinuria, reduced kidney function, focal segmental glomerulosclerosis or GBM thickening and lamellation on biopsy, sensorineural hearing loss, or a family history of progressive kidney disease (StatPearls; Kidney Medicine 2020). Across all carriers, GeneReviews (2025) estimates the absolute risk at significantly lower than 3%.
Monitor: blood pressure, urine albumin-to-creatinine ratio and eGFR, yearly if the ratio is under 30 mg/g and every 6 months if it is higher (GeneReviews).
Treat: start an ACE inhibitor or ARB when albuminuria appears or blood pressure rises; Merck also lists frequent gross hematuria and flank pain as reasons. Immunosuppression has no role.
Kidney donation: heterozygous carriers are discouraged from living donation. GeneReviews calls it a last-resort option, not advisable before age 40 or at any age with signs of kidney damage.
Counseling: autosomal dominant, so each child has a 50% chance of inheriting the variant.

How USMLE tests it

Stem clue	Think
Well patient, years of microscopic hematuria, relative with the same, normal C3, negative IF	TBMD
Thin GBM on EM, uniform, no lamellation	TBMD (but early Alport in a child, or a female with a COL4A5 variant, can look the same)
Hematuria plus sensorineural hearing loss, anterior lenticonus, progressive CKD; basket-weave GBM	Alport syndrome
Gross hematuria 1-2 days after an upper respiratory infection; mesangial IgA	IgA nephropathy
Cola urine, edema and hypertension 1-3 weeks after pharyngitis; low C3	PSGN
Low complement, mixed nephritic-nephrotic picture, hepatitis B or C, double contours ("tram-track")	MPGN (MPGN breakdown)
Rapidly rising creatinine, hemoptysis, linear IgG	Anti-GBM disease

Use the pedigree: father-to-son transmission rules out X-linked Alport; affected males connected through unaffected or mildly affected women suggests it.
Don't call it "benign familial hematuria" and stop. Follow-up answers favor monitoring blood pressure, albuminuria and eGFR.

Key takeaways

TBMD = isolated, persistent glomerular microscopic hematuria + uniformly thin GBM (about 150-225 nm vs 300-400 nm normal) + normal kidney function.
Known cause: a heterozygous COL4A3 or COL4A4 variant (not found in every patient), autosomal dominant; many references now call it autosomal dominant Alport syndrome, part of the Alport spectrum.
LM normal, IF negative, complement normal; IF separates it from IgA nephropathy, PSGN and anti-GBM disease.
Alport (mostly X-linked COL4A5) adds hearing loss, anterior lenticonus, progressive CKD and a basket-weave GBM; father-to-son transmission excludes X-linked disease.
Usually an excellent prognosis, but kidney failure risk rises to roughly 20% with proteinuria, reduced GFR or FSGS: monitor blood pressure, albuminuria and eGFR; ACE inhibitor or ARB once albuminuria appears.
When confirmation is needed, genetic testing (COL4A3, COL4A4, COL4A5) is preferred over biopsy; carriers are discouraged from living kidney donation.